-+ 0.00%
-+ 0.00%
-+ 0.00%

Cocrystal Pharma Q2 EPS $(0.23) Misses $(0.17) Estimate, Sales $105.000K

Benzinga·08/13/2026 12:23:37
Listen to the news
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.17) by 43.75 percent. This is a 15 percent decrease over losses of $(0.20) per share from the same period last year. The company reported $105.000 thousand in sales this quarter.